UCB, a global biopharmaceutical company, today announced three-year data from the BE HEARD trials for BIMZELX® (bimekizumab-bkzx) in moderate-to-severe hidradenitis suppurativa (HS). BIMZELX, the ...
Alps ordinary shares to list on the Nasdaq under the symbol “ALPS” on October 31, 2025KUALA LUMPUR, Malaysia and NEWARK, Del.
According to reports, the quality of life across OECD countries has significantly improved in the last decade. High ...